Sharechat Logo

Australia's Evolution seeks clearance to take over Acurity Health, would sell Boulcott hospital

Wednesday 19th August 2015

Text too small?

Evolution Healthcare, the Australian healthcare investor, wants to buy out its partners in private hospital operator Acurity Healthcare, and would offload its Boulcott facility in Lower Hutt to ease any competition concerns.

The Sydney-based company has applied to the Commerce Commission for clearance to buy the 88 percent of Acurity holding company Austron that it doesn't own, and included a commitment to sell the Boulcott site, it said in a statement. Evolution's ownership of Boulcott delayed the Australian investor's joint venture with the Stewart family and Royston Health Trust Board to take Acurity private last year, and led to Evolution having to water down its stake in the holding company.

"We are committed to building our footprint in the NZ market, and to increasing the options and service available to people requiring care in the private health space," Evolution said. "Unfortunately, this means we have to sell Boulcott. However, this will result in us moving to fast-track the redevelopment of Wakefield hospital."

The group convinced minority shareholders to sell up last year in a deal that valued Acurity at $112.2 million, with the proposed upgrade of the flagship Wakefield hospital set to cost north of $50 million, something they claimed the public company wasn't equipped to deal with.

The deal is contingent on antitrust regulator and Overseas Investment Office approval.

Acurity chief executive Ian England said Evolution's ability to raise funds would be a boon to the redevelopment project, and the hospital operator would be able to reap procurement gains from being part of larger group.

 

 

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

EXPRESSION OF INTEREST IN THE SUPPLY OF MEREENIE GAS
IPL - FY24 Annual Results
CEN - Contact to revisit Wairākei development options
May 17th Morning Report
PaySauce to announce full year results on 22 May 2024
BGP - Results of Briscoe Group Limited Annual Shareholder Meeting
Judith Swales to leave Fonterra
Fonterra announces step-change in strategic direction
USX Trading Results 15th May
Devon Funds Morning Note - 15 May 2024